Cargando…
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
Triple Negative Breast Cancers (TNBC) is a heterogeneous disease at the molecular and clinical level with poor outcome. Molecular subclassification of TNBCs is essential for optimal use of current therapies and for development of new drugs. microRNAs (miRNA) are widely recognized as key players in c...
Autores principales: | Gasparini, Pierluigi, Cascione, Luciano, Fassan, Matteo, Lovat, Francesca, Guler, Gulnur, Balci, Serdar, Irkkan, Cigdem, Morrison, Carl, Croce, Carlo M., Shapiro, Charles L., Huebner, Kay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012726/ https://www.ncbi.nlm.nih.gov/pubmed/24632568 |
Ejemplares similares
-
Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
por: Gasparini, Pierluigi, et al.
Publicado: (2014) -
Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
por: Cascione, Luciano, et al.
Publicado: (2013) -
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7
por: Cui, Ri, et al.
Publicado: (2015) -
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies
por: Drusco, Alessandra, et al.
Publicado: (2015) -
MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency
por: Fong, Louise Y., et al.
Publicado: (2016)